LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate ...

Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Discover ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...

LifeVantage shares soared Wednesday after the company said its financial outlook for 2025 is brighter than previously expected. The health and nutrition company's stock rose 30% to $21.40 in morning ...

Check the time stamp on this data. Updated AI-Generated Signals for Lifevantage Corporation (LFVN) available here: LFVN. Type ...

In the last week, the United States market has been flat, yet it has seen a 23% increase over the past year with earnings forecasted to grow by 15% annually. In such a dynamic environment, identifying ...

Corporation announces the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of ...